Learn About the Santerre Biomedical Polymer Lab for Tissue Engineering and Drug Delivery
The Santerre group in collaboration with fellow biomaterials, biomechanics and engineering scientists are exploring the application of tissue engineering principles for the development of cardiovascular tissue that has mechanical, cellular and physiological properties comparable to that of native healthy tissue.
Design of new polyurethane biomaterials for tissue engineering applications.
Use of polymer-based delivery platforms for controlled release of drug.
Synthesizing new dental resin polymers to minimize degradation at the filling site and reduce the risk of secondary caries.
Collaborative work in the Santerre Lab focuses on regeneration of the annulus fibrosis using electrospun scaffolds and dynamic culture techniques.
At the Santerre Lab, focus is placed on innovation with a drive to commercialize. A spin-off biomedical polymer company, Interface Biologics Inc., started in the lab over a decade ago.